Dr. Shelley Hannah Kay Howell, PHD, JD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1791 Arastradero Rd, Palo Alto, CA 94304 Phone: 650-433-3856 |
Miss Yi-hua Lin Psychologist Medicare: Not Enrolled in Medicare Practice Location: 650 Clark Way, Palo Alto, CA 94304 Phone: 510-990-5694 |
Dr. Peter J. Berman, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 900 Welch Rd, Suite #204, Palo Alto, CA 94304 Phone: 650-493-6055 |
Michael Hahn, MICHAEL HAHN Psychologist Medicare: Not Enrolled in Medicare Practice Location: 780 Welch Rd, 207, Palo Alto, CA 94304 Phone: 650-321-0365 Fax: 650-321-3460 |
Mark Beidelman Psychologist Medicare: Not Enrolled in Medicare Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 |
Dr. David Arnot Rasch, PHD Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 2555 Park Blvd, Palo Alto, CA 94306 Phone: 650-799-1569 |
Vahe Sarkissian Psychologist - Cognitive & Behavioral Medicare: Not Enrolled in Medicare Practice Location: 3351 Alma St Apt 203, Palo Alto, CA 94306 Phone: 650-493-5000 |
Dr. Maureen Satyshur, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 401 Quarry Rd, Palo Alto, CA 94304 Phone: 650-736-0800 |
Julia Elizabeth Kasl-godley, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 3801 Miranda Ave # 116b, Palo Alto, CA 94304 Phone: 650-493-5000 |
Dr. Heather Lynn Taylor, PH.D. Psychologist - Clinical Child & Adolescent Medicare: Not Enrolled in Medicare Practice Location: 2555 Park Blvd Ste 1, Palo Alto, CA 94306 Phone: 650-322-5910 |
Dr. Laurie Leventhal-belfer, PHD Psychologist - Clinical Child & Adolescent Medicare: Not Enrolled in Medicare Practice Location: 935 Middlefield Rd, Palo Alto, CA 94301 Phone: 650-322-4431 |
Dr. Nicola A Croll, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 650 Clark Way, Palo Alto, CA 94304 Phone: 650-617-3878 |
Dr. Janice D. Mill, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 550 Hamilton Ave, Suite 240, Palo Alto, CA 94301 Phone: 650-325-6834 Fax: 650-328-6600 |
Emily R Cree, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 650 Clark Way, Palo Alto, CA 94304 Phone: 650-326-5530 Fax: 650-688-3636 |
Dr. Megan Mcconnell, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 366 S California Ave, Suite #14, Palo Alto, CA 94306 Phone: 650-614-0014 |
Jessie Jong-chee Wong, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 |
Hui-tsun Theresa Chang, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 650 Clark Way, Palo Alto, CA 94304 Phone: 650-326-5530 Fax: 650-688-3669 |
Ranak B Trivedi Psychologist Medicare: Medicare Enrolled Practice Location: 300 Pasteur Dr, Palo Alto, CA 94304 Phone: 650-723-2515 |
Julia Austin, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 417 Tasso St, Palo Alto, CA 94301 Phone: 650-323-5800 |
Karen E Otte, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 550 Hamilton Ave Ste 240, Palo Alto, CA 94301 Phone: 415-517-1606 |
News Archive
How a second wave of COVID-19 infections may evolve across Europe over the next few months, using data on infection rates and travel within and between European countries, is modelled in a Scientific Reports paper.
Phase II study findings show only marginal positive effects of third-line treatment with afatinib for advanced non-small-cell lung cancer in patients with wild-type epidermal growth-factor receptor tumour status.
W. L. Gore & Associates (Gore) today reported the first clinical use in the U.S. of the GOREĀ® VIABAHNĀ® Endoprosthesis with Heparin Bioactive Surface on a lower profile delivery system. The GORE VIABAHN Device is designed to percutaneously treat Superficial Femoral Artery (SFA) and iliac peripheral artery disease by relining the native vessel.
Anchor Therapeutics today announced an initial closing of $10 million in a Series B financing. The investment is being led by current investors TVM Capital, HealthCare Ventures and the Novartis Option Fund. The company is in continuing discussions with additional investors interested in joining the Series B. Anchor Therapeutics is focused on developing peptide drug candidates, called pepducins, that modulate G protein coupled receptors (GPCRs), particularly those historically difficult to target using standard pharmaceutical approaches.
A new helper in the fight against cancer and other diseases of the gut may be genetically altered bacteria that release medicines to tumors or the gut.
› Verified 7 days ago